James Hambro & Partners Buys 22,086 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)


Share on StockTwits

James Hambro & Partners raised its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 389.8% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 27,752 shares of the medical equipment provider’s stock after purchasing an additional 22,086 shares during the period. Intuitive Surgical makes up approximately 1.9% of James Hambro & Partners’ holdings, making the stock its 18th biggest position. James Hambro & Partners’ holdings in Intuitive Surgical were worth $20,529,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of ISRG. Van ECK Associates Corp lifted its holdings in shares of Intuitive Surgical by 10.6% during the 3rd quarter. Van ECK Associates Corp now owns 7,838 shares of the medical equipment provider’s stock worth $5,561,000 after acquiring an additional 753 shares during the period. Burney Co. bought a new position in shares of Intuitive Surgical during the 3rd quarter worth about $213,000. Diversified Trust Co lifted its holdings in shares of Intuitive Surgical by 23.9% during the 4th quarter. Diversified Trust Co now owns 1,089 shares of the medical equipment provider’s stock worth $891,000 after acquiring an additional 210 shares during the period. Donaldson Capital Management LLC lifted its holdings in shares of Intuitive Surgical by 11.7% during the 4th quarter. Donaldson Capital Management LLC now owns 1,244 shares of the medical equipment provider’s stock worth $1,018,000 after acquiring an additional 130 shares during the period. Finally, Louisiana State Employees Retirement System increased its position in shares of Intuitive Surgical by 110.2% during the 4th quarter. Louisiana State Employees Retirement System now owns 12,400 shares of the medical equipment provider’s stock worth $10,144,000 after purchasing an additional 6,500 shares in the last quarter. 86.50% of the stock is owned by hedge funds and other institutional investors.

NASDAQ ISRG opened at $867.55 on Tuesday. Intuitive Surgical, Inc. has a 12-month low of $495.55 and a 12-month high of $893.79. The company has a market capitalization of $102.73 billion, a PE ratio of 98.81, a price-to-earnings-growth ratio of 8.96 and a beta of 0.98. The firm’s 50 day moving average is $780.58 and its 200-day moving average is $763.55.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Monday, April 19th. The medical equipment provider reported $3.52 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.63 by $0.89. Intuitive Surgical had a net margin of 24.45% and a return on equity of 12.08%. The company had revenue of $1.29 billion for the quarter, compared to the consensus estimate of $1.11 billion. During the same period last year, the company earned $2.69 earnings per share. The firm’s revenue was up 17.5% compared to the same quarter last year. On average, sell-side analysts predict that Intuitive Surgical, Inc. will post 8.02 earnings per share for the current fiscal year.

In related news, EVP Curet Myriam sold 379 shares of the business’s stock in a transaction on Tuesday, March 2nd. The shares were sold at an average price of $760.00, for a total transaction of $288,040.00. Following the transaction, the executive vice president now directly owns 846 shares in the company, valued at $642,960. The sale was disclosed in a filing with the SEC, which is available through this link. Also, VP Robert Desantis sold 2,958 shares of Intuitive Surgical stock in a transaction on Wednesday, February 17th. The stock was sold at an average price of $782.00, for a total transaction of $2,313,156.00. Over the last 90 days, insiders have sold 31,780 shares of company stock worth $26,987,343. 1.60% of the stock is owned by corporate insiders.

Several equities research analysts have weighed in on ISRG shares. Raymond James raised their price objective on shares of Intuitive Surgical from $800.00 to $865.00 and gave the company an “outperform” rating in a research report on Friday, January 22nd. JPMorgan Chase & Co. raised their price objective on shares of Intuitive Surgical from $840.00 to $900.00 and gave the company an “overweight” rating in a research report on Wednesday, April 21st. Oppenheimer upgraded shares of Intuitive Surgical from an “underperform” rating to a “market perform” rating in a research report on Tuesday, April 27th. Morgan Stanley raised their target price on shares of Intuitive Surgical from $780.00 to $855.00 and gave the company an “equal weight” rating in a research note on Tuesday, April 27th. Finally, Wells Fargo & Company raised their target price on shares of Intuitive Surgical from $879.00 to $892.00 and gave the company an “overweight” rating in a research note on Wednesday, April 21st. Eight research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average target price of $805.95.

About Intuitive Surgical

Intuitive Surgical, Inc engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. Its products include Da Vinci and Ion. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

See Also: Gap Up Stocks

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.